Targeting tumor-associated sympathetic nerves orchestrates tertiary lymphoid structures to enhance PD-1/PD-L1 blockade efficacyZhiqin Zeng, Cheng Pan, Yedi Huang et al.|International Immunopharmacology|2026Cited by 0